Anna Czarnecka

Professor

Maria Sklodowska-Curie National Research Institute of Oncology

Poland

Research Interests

Explore related searches

Professors in Poland Professors in Medical Imaging Medical Imaging professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Anna Czarnecka is a faculty member at The Maria Sklodowska-Curie National Research Institute of Oncology in Poland. Her research focuses on oncology, with an emphasis on chemotherapy outcomes in soft tissue sarcomas and melanoma, as well as the mechanisms of resistance to immunotherapy. She has published extensively on topics including neoadjuvant treatment strategies and the clinical implications of genomic testing in solid cancers.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (14)

Paweł Sobczuk

Medical University of Warsaw

POLAND

View details

Paweł Teterycz

Maria Sklodowska-Curie National Research Institute of Oncology

POLAND

View details

Narodowy Instytut Onkologii im Marii Skłodowskiej-Curie Państwowy Instytut Badawczy w Warszawie

POLAND

View details

Kamil Drucis

Medical University of Gdansk

POLAND

View details

Wieslaw Bal

Narodowy Instytut Onkologii im Marii Skłodowskiej-Curie Państwowy Instytut Badawczy w Warszawie

POLAND

View details

Piotr Rutkowski

Narodowy Instytut Onkologii im Marii Skłodowskiej-Curie Państwowy Instytut Badawczy w Warszawie

POLAND

View details

Bozena Cybulska-Stopa

Chief

Wrocław University of Scince and Technology

POLAND

View details

BARTLOMIEJ SZOSTAKOWSKI

Narodowy Instytut Onkologii im Marii Skłodowskiej-Curie Państwowy Instytut Badawczy w Warszawie

POLAND

View details

Michal Fiedorowicz

Assistant Professor

Mossakowski Medical Research Centre

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Anna Czarnecka

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Long-term outcomes of sequential chemotherapy in epithelioid sarcoma

Discontinuation of Immune Checkpoint Inhibition in Patients with Advanced Unresectable Melanoma Achieving CR, PR, or SD

Real-world outcomes of metastatic clear cell sarcoma sequential chemotherapy

Mechanisms of Resistance to Anti-PD-1 Immunotherapy in Melanoma and Strategies to Overcome It

Establishing biomarkers for soft tissue sarcomas

Molecular and Clinicopathological Biomarkers in the Neoadjuvant Treatment of Patients with Advanced Resectable Melanoma

ESMO Recommendations on clinical reporting of genomic test results for solid cancers.

Surgical Textbook Outcomes in the Era of Neoadjuvant Systemic Treatment for Skin Cancers

Long‐term efficacy of neoadjuvant–adjuvant targeted therapy in borderline resectable stage IIIB–D and IV melanoma

Preoperative-postoperative immunotherapy as treatment of borderline resectable and oligoprogressive stage III B-D and IV melanoma

Mesenchymal Chondrosarcoma from Diagnosis to Clinical Trials

Dedifferentiated Chondrosarcoma from Molecular Pathology to Current Treatment and Clinical Trials

Predictive Biomarkers of Pathological Response to Neoadjuvant Chemoradiotherapy for Locally Advanced Soft Tissue Sarcomas

The Current Treatment Trends and Survival Patterns in Melanoma Patients with Positive Sentinel Lymph Node Biopsy (SLNB): A Multicenter Nationwide Study

Epigenetic Abnormalities in Chondrosarcoma

Myocarditis Induced by Immunotherapy in Metastatic Melanoma—Review of Literature and Current Guidelines

Long Term Results and Prognostic Biomarkers for Anti-PD1 Immunotherapy Used after BRAFi/MEKi Combination in Advanced Cutaneous Melanoma Patients

Efficacy of immunotherapy beyond RECIST progression in advanced melanoma: a real-world evidence

Imaging of Uveal Melanoma—Current Standard and Methods in Development

Cancer Stem Cell Markers in Rhabdomyosarcoma in Children

Collaborators (14)

Paweł Sobczuk

Paweł Teterycz

Marcin Kleibert

Dorota Sulejczak

Anna Szumera-Ciećkiewicz

Rafal Suwinski

Peter Horak

Tomasz Switaj

Kamil Drucis

Wieslaw Bal

Piotr Rutkowski

Bozena Cybulska-Stopa

BARTLOMIEJ SZOSTAKOWSKI

Michal Fiedorowicz

Make your next move.